Lung/Non-Small Cell - Marquette General Cancer Center at Marquette General Health System

For medical emergencies in Marquette County, dial 911

Marquette General Cancer Center







>>	Text Page
>>	Cancer Center Home

>>	Welcome to MGHS
>>	Baby Page
>>	Clinic Information
>>	E-mail Patients
>>	Employment
>>	Marquette General Foundation
>>	Health Information
>>	Laboratory
>>	On Line Bill Payments
>>	On Line Registration
>>	Patient Feedback
>>	MGHS News
>>	Poison Guide
>>	Physician Employment
>>	Physician Page
>>	Internet Search
>>	Search MGHS Web Site

Lung/Non-Small Cell

Study Name - RTOG 0617/NCCTG

Study Description -
A RANDOMIZED PHASE III COMPARISON OF STANDARD- DOSE (60 Gy) VERSUS HIGHDOSE
(74 Gy) CONFORMAL RADIOTHERAPY WITH CONCURRENT AND
CONSOLIDATION CARBOPLATIN/PACLITAXEL IN PATIENTS WITH STAGE IIIA/IIIB
NON-SMALL CELL LUNG CANCER

IRB Open Date - 11-27-2007

Consent-Form

Data Privacy Statement for Research Studies

Study Name - CTSU_E1505

Study Description -
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (> 4cm) IIIA Non-Small Cell Lung Cancer (NSCLC).

IRB Open Date - 08-08-2007

Consent-Form

Data Privacy Statement for Research Studies

Study Name - SWOG 9925

Study Description -
Lung cancer specimen repository protocol, ancillary

IRB Open Date - 10-11-2000

Data Privacy Statement for Research Studies

<< Back

Patient Rooms Direct Dialing - (906) 225-3(Room#).
Room #'s: 233-245, 374-390, 501-527, & 601-827